Literature DB >> 24430560

Stem cell therapies and regenerative medicine in China.

Sha Huang1, XiaoBing Fu.   

Abstract

Stem cells are the core of tissue repair and regeneration, and a promising cell source for novel therapies. In recent years, research into stem cell therapies has been particularly exciting in China. The remarkable advancements in basic stem cell research and clinically effective trials have led to fresh insights into regenerative medicine, such as treatments for sweat gland injury after burns, diabetes, and liver injury. High hopes have inspired numerous experimental and clinical trials. At the same time, government investment and policy support of research continues to increase markedly. However, numerous challenges must be overcome before novel stem cell therapies can achieve meaningful clinical outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 24430560     DOI: 10.1007/s11427-014-4608-3

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  2 in total

1.  Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations.

Authors:  Qi Gu; Juan Wang; Lei Wang; Zheng-Xin Liu; Wan-Wan Zhu; Yuan-Qing Tan; Wei-Fang Han; Jun Wu; Chun-Jing Feng; Jin-Hui Fang; Lei Liu; Liu Wang; Wei Li; Xiao-Yang Zhao; Bao-Yang Hu; Jie Hao; Qi Zhou
Journal:  Stem Cell Reports       Date:  2017-05-11       Impact factor: 7.765

2.  The Characteristics of Human Resources and Related Research Activities among Basic Stem Cell Research Groups in China.

Authors:  Sheng-Jun Wang; Li-Juan Liu; Guang-Yue Ji; Xiao-Hua Andrew Zhou; Tian-Jiao Jiang; Mei-Hua Lu; De-Lin Yu; Qiang Guo; Jin-Hai Sun
Journal:  Iran J Public Health       Date:  2019-01       Impact factor: 1.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.